Naturally occurring soluble receptors are generated by several mechanisms including proteolytic cleavage of surface-bound ectodomains, alternative splicing, and extracellular release of membrane-bound receptors from exosomes. Once generated, soluble receptors can act as either agonists or antagonists and dysregulation of these signaling pathways are often associated with immunopathologies, certain malignancies, and n eurodegenerative disorders. We offer a wide-range of bioactive, recombinant soluble receptors that have been constructed to encode only the extracellular domain of the protein. |
|
|
Human OX40/TNFRSF4-Fc Chimera | Mouse IL-17RA-Fc Chimera |
Human OX40/TNFRSF4-Fc Chimera binds to immobilized human OX40L (1.0 µg/mL) with an EC50 of 20 - 80 ng/mL. HRP Protein A was used to detect binding. | Mouse IL-17RA inhibits induction of IL-6 by recombinant IL-17A in fetal mouse skin fibroblasts with an ED50 of 0.02-0.12 ng/mL. |
If you’re studying cell signaling pathways, try one of our phospho-specific antibodies for critical targets in pathways related to cell growth, proliferation, and health including: RPS6 Phospho (Ser235/Ser236), mTOR Phospho (Ser2448), ERK1/2 (Thr202/Tyr204), and p38 MAPK Phospho (Thr180/Tyr182). |
Follow Us